Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual vs Oral Tizanidine for Spasticity in MS
NCT00358293Phase 2Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tizanidine in Spasticity, sponsored by Teva Pharmaceutical Industries Ltd.. Started Dec 2006; status: completed.
02
Drugs
tizanidine
03
Conditions
Spasticity
Beyond the preview
Go deeper on NCT00358293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00358293.